These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24375594)

  • 1. The immunosuppressant tributyltin oxide blocks the mTOR pathway, like rapamycin, albeit by a different mechanism.
    Osman AM; van Loveren H
    J Appl Toxicol; 2014 Dec; 34(12):1361-7. PubMed ID: 24375594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide: TBTO affects proliferation and energy sensing pathways.
    Osman AM; van Loveren H
    Toxicol Sci; 2012 Mar; 126(1):84-100. PubMed ID: 22174045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
    El-Chaâr D; Gagnon A; Sorisky A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphorylation profiling identifies potential mechanisms for direct immunotoxicity.
    Shao J; Stout I; Hendriksen PJ; van Loveren H; Peijnenburg AA; Volger OL
    J Immunotoxicol; 2016; 13(1):97-107. PubMed ID: 25715851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
    Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin (Sirolimus) alters mechanistic target of rapamycin pathway regulation and microRNA expression in mouse meiotic spermatocytes.
    Mukherjee A; Koli S; Reddy KV
    Andrology; 2015 Sep; 3(5):979-90. PubMed ID: 26311343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two novel inhibitors of mTOR signaling pathway based on high content screening.
    Yan J; Zhou H; Kong L; Zhang J; Zhao Q; Li Y
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):799-808. PubMed ID: 23934262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
    Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
    Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver.
    Jiang YP; Ballou LM; Lin RZ
    J Biol Chem; 2001 Apr; 276(14):10943-51. PubMed ID: 11278364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
    Tang X; Wang L; Proud CG; Downes CP
    Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide.
    Bauchart-Thevret C; Cui L; Wu G; Burrin DG
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E899-909. PubMed ID: 20841502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
    Rosner M; Hengstschläger M
    Oncogene; 2011 Nov; 30(44):4509-22. PubMed ID: 21602892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
    Wan X; Mendoza A; Khanna C; Helman LJ
    Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.